Bio-Gate AG logo

Bio-Gate AG (BIG1)

Market Open
11 Aug, 06:01
XMUN XMUN
2. 94
0
0%
- Market Cap
- P/E Ratio
- Div Yield
27 Volume
- Eps
2.94
Previous Close
Add Transaction
Day Range
2.94 2.94
Year Range
2.61 4.75
Want to track BIG1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BIG1 trading today higher at €2.94, an increase of 0% from yesterday's close, completing a monthly decrease of -5.1613% or -€0.16. Over the past 12 months, BIG1 stock gained 260.7362%.
BIG1 is not paying dividends to its shareholders.
The last earnings report, released on Feb 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Bio-Gate AG has completed 1 stock splits, with the recent split occurring on Jul 28, 2026.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XETRA (EUR).

BIG1 Chart

Bio-Gate AG (BIG1) FAQ

What is the stock price today?

The current price is €2.94.

On which exchange is it traded?

Bio-Gate AG is listed on XMUN.

What is its stock symbol?

The ticker symbol is BIG1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Bio-Gate AG ever had a stock split?

Bio-Gate AG had 1 splits and the recent split was on Jul 28, 2026.

Bio-Gate AG Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Marc Lloret-Grau CEO
XMUN Exchange
DE000BGAG981 ISIN
Germany Country
- Employees
- Last Dividend
28 Jul 2026 Last Split
- IPO Date

Overview

Bio-Gate AG is a prominent company headquartered in Nuremberg, Germany, specializing in the development of technologies and tailored solutions aimed at enhancing health and hygiene standards. Since its establishment in 2005, the company has been at the forefront of integrating advanced materials and solutions into products designed to combat microbial contamination and promote sterile environments. Operating primarily in Germany, Bio-Gate AG caters to a wide range of clients, including large and medium-sized entities within the medical technology sector, pharmaceutical distributors, various industrial companies, public sector entities, and institutions with a critical need for maintaining high hygiene standards.

Products and Services

Bio-Gate AG has developed a suite of innovative products and technology solutions focused on microbial resistance and hygiene enhancement, notably:

  • HyProtect: A plasma coating technology specifically designed to protect the surfaces of medical implants from bacterial colonization. This innovative solution ensures that implants remain sterile and significantly reduces the risk of post-surgical infections. By applying this advanced coating, Bio-Gate AG provides a crucial tool for improving patient outcomes and enhancing the longevity and safety of medical implants.
  • MicroSilver BG™: This product consists of elemental microporous silver additives that offer antimicrobial properties. MicroSilver BG™ is engineered to be integrated into a wide array of products, including those outside the medical field, to confer durable microbial resistance. Its versatile nature allows for application across diverse industries, providing protection against bacteria, fungi, and other harmful microorganisms on treated surfaces. The incorporation of MicroSilver BG™ into products aligns with growing market demands for hygiene solutions that are both effective and sustainable.

Contact Information

Address: Neumeyerstrasse 28-34
Phone: 49 9 11 47 75 23